Huw M. Nash

Companies

• Stoke Therapeutics, Inc.Chief Business Officer Jul 3, 2024 to Jul 3, 2024¹
• Stoke Therapeutics, Inc.Chief operating officer Jun 18, 2019 to Jun 7, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• STStoke Therapeutics, Inc. STOK0 shares³Jul 2, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 2, 2024Sold 33 shares at $13.90 of Stoke Therapeutics, Inc.³
• Jul 2, 2024Sold 2,467 shares at $13.10 of Stoke Therapeutics, Inc.³
• May 20, 2024Sold 50,000 shares at $15.39 of Stoke Therapeutics, Inc.⁴
• May 20, 2024Exercised options 50,000 shares at $0.40 of Stoke Therapeutics, Inc.⁴
• Apr 1, 2024Sold 400 shares at $13.61 of Stoke Therapeutics, Inc.⁵
• Apr 1, 2024Sold 60,929 shares at $13.22 of Stoke Therapeutics, Inc.⁵
• Apr 1, 2024Exercised options 50,000 shares at $0.40 of Stoke Therapeutics, Inc.⁵
• Mar 19, 2024Sold 4,116 shares at $6.10 of Stoke Therapeutics, Inc.⁶
• Mar 15, 2024Exercised options 13,100 shares of Stoke Therapeutics, Inc.⁶
• Jan 3, 2022Sold 200 shares at $24.07 of Stoke Therapeutics, Inc.⁷
• Jan 3, 2022Sold 2,103 shares at $23.40 of Stoke Therapeutics, Inc.⁷
• Jan 3, 2022Sold 1,497 shares at $22.47 of Stoke Therapeutics, Inc.⁷
• Jan 3, 2022Exercised options 3,800 shares at $2.19 of Stoke Therapeutics, Inc.⁷
• Dec 1, 2021Sold 2,500 shares at $25.06 of Stoke Therapeutics, Inc.⁸
• Dec 1, 2021Sold 3,200 shares at $23.96 of Stoke Therapeutics, Inc.⁸
• Dec 1, 2021Exercised options 5,700 shares at $2.19 of Stoke Therapeutics, Inc.⁸
• Nov 3, 2021Sold 1,900 shares at $25.00 of Stoke Therapeutics, Inc.⁹
• Nov 3, 2021Exercised options 1,900 shares at $2.19 of Stoke Therapeutics, Inc.⁹
• Nov 1, 2021Sold 1,610 shares at $23.72 of Stoke Therapeutics, Inc.⁹
• Nov 1, 2021Sold 2,190 shares at $23.41 of Stoke Therapeutics, Inc.⁹
• Nov 1, 2021Exercised options 3,800 shares at $2.19 of Stoke Therapeutics, Inc.⁹
• Oct 1, 2021Sold 5,700 shares at $24.83 of Stoke Therapeutics, Inc.¹⁰
• Oct 1, 2021Exercised options 5,700 shares at $2.19 of Stoke Therapeutics, Inc.¹⁰